The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 210, doi. 10.1007/s11102-015-0677-y
- By:
- Publication type:
- Article
Works matching IS 1386341X AND DT 2016 AND VI 19 AND IP 2
Results: 14
1
2
Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 149, doi. 10.1007/s11102-015-0693-y
- By:
- Publication type:
- Article
3
Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 158, doi. 10.1007/s11102-015-0694-x
- By:
- Publication type:
- Article
4
Algorithm development and the clinical and economic burden of Cushing's disease in a large US health plan database.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 167, doi. 10.1007/s11102-015-0695-9
- By:
- Publication type:
- Article
5
Significant improvement of intractable headache after transsphenoidal surgery in patients with pituitary adenomas; preoperative neuroradiological evaluation and intraoperative intrasellar pressure measurement.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 175, doi. 10.1007/s11102-015-0696-8
- By:
- Publication type:
- Article
6
Comprehensive evaluation of thyrotropinomas: single-center 20-year experience.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 183, doi. 10.1007/s11102-015-0697-7
- By:
- Publication type:
- Article
7
Intraoperative magnetic resonance imaging assessment of non-functioning pituitary adenomas during transsphenoidal surgery.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 222, doi. 10.1007/s11102-015-0679-9
- By:
- Publication type:
- Article
8
A prospective study of appetite and food craving in 30 patients with Cushing's disease.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 117, doi. 10.1007/s11102-015-0690-1
- By:
- Publication type:
- Article
9
Safety of long-term treatment with Pegvisomant: analysis of Spanish patients included in global ACROSTUDY.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 127, doi. 10.1007/s11102-015-0691-0
- By:
- Publication type:
- Article
10
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's disease.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 138, doi. 10.1007/s11102-015-0692-z
- By:
- Publication type:
- Article
11
New oral anticoagulants and pituitary apoplexy.
- Published in:
- 2016
- By:
- Publication type:
- Letter
12
Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 202, doi. 10.1007/s11102-015-0699-5
- By:
- Publication type:
- Article
13
Prof. Jens Sandahl Christiansen.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 115, doi. 10.1007/s11102-016-0705-6
- Publication type:
- Article
14
A comparative analysis of ESM-1 and vascular endothelial cell marker (CD34/CD105) expression on pituitary adenoma invasion.
- Published in:
- Pituitary, 2016, v. 19, n. 2, p. 194, doi. 10.1007/s11102-015-0698-6
- By:
- Publication type:
- Article